BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12706678)

  • 1. Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough.
    Giammanco A; Taormina S; Chiarini A; Dardanoni G; Stefanelli P; Salmaso S; Mastrantonio P
    Vaccine; 2003 May; 21(17-18):1924-31. PubMed ID: 12706678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children.
    Hendrikx LH; Schure RM; Oztürk K; de Rond LG; de Greeff SC; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Sep; 29(40):6874-80. PubMed ID: 21803088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
    J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine.
    Zackrisson G; Lagergård T; Trollfors B
    J Clin Microbiol; 1989 Jul; 27(7):1567-71. PubMed ID: 2768444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution of specific IgG subclasses in patients with pertussis and in healthy persons].
    Zaĭtsev EM; Mazurova IK; Petrova MS; Krasnoproshina LI; Astakhova TI; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):57-61. PubMed ID: 19459479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
    Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
    Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody Specificity Following a Recent
    Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
    Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
    J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contents of antibodies to Bordetella pertussis antigens in patients with rheumatic diseases].
    Kostinov MP; Tarasova AA; Zaĭtsev EM
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):61-4. PubMed ID: 18277540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.
    Dalby T; Sørensen C; Petersen JW; Krogfelt KA
    APMIS; 2010 Dec; 118(12):968-72. PubMed ID: 21091778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.
    Socan M; Prosenc K; Vegnuti M
    Wien Klin Wochenschr; 2006 Jun; 118(11-12):336-40. PubMed ID: 16855922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y; Sato H
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
    van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
    Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.